Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lanhuayao is a traditional Chinese medicine (TCM) formulated as water pills. It is developed and manufactured by Dalian Merro Traditional Chinese Medicine Factory and other regional manufacturers. The formulation consists of ten traditional ingredients, including Borax (硼砂), Bornelum Syntheticum (冰片), Indigo Naturalis (青黛), Natrii Sulfas Exsiccatus (玄明粉), Talcum (滑石粉), Succinum (琥珀), Alumen Dehydratum (枯矾), Gypsum Fibrosum (石膏), Catechu (儿茶), and Picrorhizae Rhizoma (胡黄连). lanhuayao is approved in China for clearing heat, detoxicating, and relieving malnutrition (消疳). It is primarily indicated for the treatment of acute and chronic tonsillitis, gingival swelling and pain, sore throat, and infantile malnutrition (小儿疳症).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lanhuayao.